Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakob Dalgaard

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 28, 2002
[Paroxysmal nocturnal hemoglobinuria--a rare disease with many faces]Jakob Dalgaard, Lorentz Brinch, Geir E Tjønnfjord
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 17, 2007
[Non-myeloablative allogeneic stem cell transplantation]Jakob Dalgaard, Yngvar Fløisand, Margurethe Stenersen, et al.
Journal of Medical Case Reports|May 12, 2024
Long-lasting severe anemia following treatment with natalizumab for relapsing-remitting multiple sclerosis: a case reportLars Henrik Dahl Hamnvik, Geir E Tjønnfjord, Signe Spetalen, et al.
Journal of Leukocyte Biology|February 25, 2005
Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsetsJakob Dalgaard, Karen J Beckstrøm, Frode L Jahnsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 8, 2019
Treatment of acute myeloid leukaemia in elderly patientsHåkon Reikvam, Jakob Dalgaard, Silje Johansen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 21, 2025
Marthe Kopland, Vigdis Skinnemoen Ottersen, Dag Olav Dahle, et al.
Blood|November 5, 2005
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infectionEspen Ø Kvale, Jakob Dalgaard, Fridtjof Lund-Johansen, et al.
Blood|July 17, 2010
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin diseaseSigbjørn Berentsen, Ulla Randen, Anne Marita Vågan, et al.
Blood|May 24, 2017
Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trialSigbjørn Berentsen, Ulla Randen, Markku Oksman, et al.
British Journal of Haematology|November 28, 2023
Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AMLOtto Emil Nyquist, Jakob Dalgaard, Signe Spetalen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 28, 2002
[Paroxysmal nocturnal hemoglobinuria--a rare disease with many faces]Jakob Dalgaard, Lorentz Brinch, Geir E Tjønnfjord
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 17, 2007
[Non-myeloablative allogeneic stem cell transplantation]Jakob Dalgaard, Yngvar Fløisand, Margurethe Stenersen, et al.
Journal of Medical Case Reports|May 12, 2024
Long-lasting severe anemia following treatment with natalizumab for relapsing-remitting multiple sclerosis: a case reportLars Henrik Dahl Hamnvik, Geir E Tjønnfjord, Signe Spetalen, et al.
Journal of Leukocyte Biology|February 25, 2005
Differential capability for phagocytosis of apoptotic and necrotic leukemia cells by human peripheral blood dendritic cell subsetsJakob Dalgaard, Karen J Beckstrøm, Frode L Jahnsen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 8, 2019
Treatment of acute myeloid leukaemia in elderly patientsHåkon Reikvam, Jakob Dalgaard, Silje Johansen, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 21, 2025
Marthe Kopland, Vigdis Skinnemoen Ottersen, Dag Olav Dahle, et al.
Blood|November 5, 2005
CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infectionEspen Ø Kvale, Jakob Dalgaard, Fridtjof Lund-Johansen, et al.
Blood|July 17, 2010
High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin diseaseSigbjørn Berentsen, Ulla Randen, Anne Marita Vågan, et al.
Blood|May 24, 2017
Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trialSigbjørn Berentsen, Ulla Randen, Markku Oksman, et al.
British Journal of Haematology|November 28, 2023
Pathogenic DDX41 variants, possible response predictors to low-dose melphalan in hypo- and normocellular MDS and AMLOtto Emil Nyquist, Jakob Dalgaard, Signe Spetalen, et al.
Pageof 2